Bicycle Therapeutics Announces First US Appointment
Bicycle Therapeutics, the UK-based biotechnology company, has appointed Rosamond Deegan president and chief of business of its newly established US operation, headquartered in Cambridge, Massachusetts. Deegan joins Bicycle Therapeutics from Trevena Inc., where she was most recently senior vice president, business development and operations, before which she was head of finance and operations. Prior to her time at Trevena, Deegan held a number of positions at GlaxoSmithKline, both in the US and the UK.
You may also be interested in...
The UK backs the world's first COVID-19 human challenge studies to accelerate research – though the first results will not be ready until mid-2021.
New chief business officer named at Ovoca Bio, and a new chairman at Opthea Ltd.
Plus Sanofi and Translate Bio release preclinical data from their COVID-19 vaccine candidate, another entrant to the now crowded mRNA vaccine field.